Research indicates that by 2050, more than 150 million people will be living with Alzheimer's disease (AD), a condition associated with neurodegeneration due to the accumulation of amyloid-beta and tau proteins. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.